These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 9349695)

  • 1. Patient participation and compliance in cancer chemoprevention trials: issues and concerns.
    Tangrea JA
    Proc Soc Exp Biol Med; 1997 Nov; 216(2):260-5. PubMed ID: 9349695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Participant enrollment, participation, and compliance in chemoprevention trials.
    Rimer BK
    Adv Exp Med Biol; 1992; 320():111-7. PubMed ID: 1442275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perceived benefits of and barriers to participation in a phase I/II colon cancer chemoprevention trial.
    Hudmon KS; Love RR; Chamberlain RM
    J Cancer Educ; 1999; 14(2):83-7. PubMed ID: 10397482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chemoprevention of cancers].
    Espie M
    Bull Cancer; 1995 Jul; 82 Suppl 3():181s-185s. PubMed ID: 7492832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conducting chemoprevention clinical trials: challenges and solutions.
    Richmond E; O'Mara A
    Semin Oncol; 2010 Aug; 37(4):402-6. PubMed ID: 20816509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
    Greenwald P
    J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical evaluation of cancer prevention agents.
    Goodman GE
    Proc Soc Exp Biol Med; 1997 Nov; 216(2):253-9. PubMed ID: 9349694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer prevention trials and primary care physicians: factors associated with recommending trial enrollment.
    Battaglia TA; Ash A; Prout MN; Freund KM
    Cancer Detect Prev; 2006; 30(1):34-7. PubMed ID: 16476525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials.
    Kelloff GJ; Boone CW; Steele VE; Crowell JA; Lubet R; Sigman CC
    Cancer Res; 1994 Apr; 54(7 Suppl):2015s-2024s. PubMed ID: 8137331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprevention of cancer.
    Tsao AS; Kim ES; Hong WK
    CA Cancer J Clin; 2004; 54(3):150-80. PubMed ID: 15195789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a model predicting enrollment status in a chemoprevention trial for breast cancer.
    Yeomans Kinney A; Vernon SW; Shui W; Weber DV; Schell M; Vogel VG
    Cancer Epidemiol Biomarkers Prev; 1998 Jul; 7(7):591-5. PubMed ID: 9681527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The behavioral dynamics of clinical trials.
    Leventhal H; Nerenz DR; Leventhal EA; Love RR; Bendena LM
    Prev Med; 1991 Jan; 20(1):132-46. PubMed ID: 2008422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethical issues: changing attitudes and practices.
    Henderson MM
    Cancer Detect Prev; 1994; 18(4):323-7. PubMed ID: 7982242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk biomarkers and current strategies for cancer chemoprevention.
    Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Malone WF; Steele VE; Lubet RA; Sigman CC
    J Cell Biochem Suppl; 1996; 25():1-14. PubMed ID: 9027592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of physician recommendation on enrollment in the Breast Cancer Chemoprevention Trial.
    Kinney AY; Richards C; Vernon SW; Vogel VG
    Prev Med; 1998; 27(5 Pt 1):713-9. PubMed ID: 9808803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoprevention of human cancer: a reasonable strategy?
    Meyskens FL
    Recent Results Cancer Res; 1999; 151():113-21. PubMed ID: 10337722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why a statin and/or another proven heart healthy agent should be utilized in the next major cancer chemoprevention trial: part II.
    Moyad MA
    Urol Oncol; 2004; 22(6):472-7. PubMed ID: 15610864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why a statin and/or another proven heart healthy agent should be utilized in the next major cancer chemoprevention trial: part I.
    Moyad MA
    Urol Oncol; 2004; 22(6):466-71. PubMed ID: 15610863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoprevention clinical trials: it is time to turn success into progress.
    Brown PH
    Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1531-2. PubMed ID: 17684123
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemoprevention of cancer.
    Greenwald P
    Sci Am; 1996 Sep; 275(3):96-9. PubMed ID: 8701300
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.